Literature DB >> 7693643

The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro.

R Jennings1, A Clegg.   

Abstract

Five spermicides including nonoxynol-9 were assessed under in-vitro conditions, for their inhibitory activity against two viruses capable of spread by sexual intercourse, herpes simplex virus type-2 (HSV-2) and the human immunodeficiency virus type-1. A further eight commercially-available spermicidal preparations containing varying concentrations of either nonoxynol-9 or nonoxynol-11 were also assessed for activity against HSV-2. All spermicides and spermicidal preparations tested showed inhibitory activity against both viruses over periods of time ranging from 30 sec to 5 min. This activity was dependent on the concentration of spermicide to which the viruses were exposed.

Entities:  

Keywords:  Clinical Research; Contraception; Contraceptive Agents; Demographic Factors; Developed Countries; Diseases; England; Europe; Family Planning; Herpes Genitalis; Hiv Infections; In Vitro; Infections; Nonoxynol-9; Northern Europe; Population; Population Dynamics; Reproductive Tract Infections; Research Methodology; Research Report; Sexually Transmitted Diseases; Spermicidal Contraceptive Agents; Time Factors; United Kingdom; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 7693643     DOI: 10.1093/jac/32.1.71

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.

Authors:  S Roy; P Gourde; J Piret; A Désormeaux; J Lamontagne; C Haineault; R F Omar; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Vaginal formulations of carrageenan protect mice from herpes simplex virus infection.

Authors:  V R Zacharopoulos; D M Phillips
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis.

Authors:  Jose A Simoes; Diane M Citron; Alla Aroutcheva; Robert A Anderson; Calvin J Chany; Donald P Waller; Sebastian Faro; Lourens J D Zaneveld
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Authors:  J Piret; J Lamontagne; J Bestman-Smith; S Roy; P Gourde; A Désormeaux; R F Omar; J Juhász; M G Bergeron
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 5.  Rectal microbicide development.

Authors:  Ian McGowan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission.

Authors:  Charlene S Dezzutti; V Nicole James; Artur Ramos; Sharon T Sullivan; Aladin Siddig; Timothy J Bush; Lisa A Grohskopf; Lynn Paxton; Shambavi Subbarao; Clyde E Hart
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 7.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

8.  Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Authors:  M C Skinner; W E Stamm; M L Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

9.  In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

Authors:  Lisa C Rohan; Bernard J Moncla; Ratiya Pamela Kunjara Na Ayudhya; Marilyn Cost; Yunda Huang; Fang Gai; Nicole Billitto; J D Lynam; Kara Pryke; Phillip Graebing; Nicole Hopkins; James F Rooney; David Friend; Charlene S Dezzutti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

10.  Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo.

Authors:  Yanille M Scott; Seo Young Park; Charlene S Dezzutti
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.